Panel discusses genetic markers of kidney disease

Glenda Roberts, director of external relations and patient engagement, Kidney Research Institute, was a panelist on the National Kidney Foundation Podcast, NKF Live.

The panel discussed a clinical research study that is looking to understand the effect of APOL1 on kidney transplant outcomes from living and deceased donors.

Some diseases run in the family, when more than one person has the same kind of illness passed down through genes. One of those genes, called APOL1, has variations that are linked to an increased risk for kidney disease, especially in under-resourced communities of color.

In this NKF Live, Roberts and panelists discuss clinical research looking to understand the effect of APOL1 on kidney transplant outcomes from living and deceased donors, and why it's important for you to be part of this research study.